Cytometry Part B-Clinical Cytometry

Papers
(The TQCC of Cytometry Part B-Clinical Cytometry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease31
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring30
Issue highlights—January 202529
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells27
23
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients18
Issue highlights—September 202316
Issue Information15
15
14
Issue Information13
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma11
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel11
Standardization of flow cytometric detection of antigen expression11
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis11
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa10
Issue Information10
ROR1 expression in mature B lymphoid neoplasms by flow cytometry9
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes9
Issue Highlights—January 20229
Issue Information9
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia9
Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma8
Issue Information8
Issue Information8
Issue Highlights — May 20218
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia7
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry7
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR7
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric7
6
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry6
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia6
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International 6
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT6
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow 6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis6
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays6
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies5
Issue Information5
5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry5
5
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Bone marrow follicular‐like T cells in monoclonal gammopathies5
5
Editorial on IVD cellular assay validation5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD74
Issue Highlights—July 20224
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet4
Analysis of human chromosomes by imaging flow cytometry4
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
Issue Information4
Issue Highlights—November 20213
Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA‐DR expression in clinical samples3
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis3
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome3
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care3
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition3
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia3
0.038249969482422